Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-08-14

Clinical Trial Update: Effect of Olmesartan on Angiotensin(1-7) Levels and Vascular Functions in Diabetes and Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of olmesartan on Angiotensin(1-7) levels and vascular functions in patients with diabetes and hypertension; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Olmesartan (olmesartan)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Angiotensin/Renin/Aldosterone Hypertension, Hypertension | Phase 4 | Status: COMPLETED